Suitors Weigh Bids for Sanofi's $3B European Generics Biz Post author:Sam Post published:January 10, 2018 Post category:BioPharma The portfolio consists of acute, chronic and oncology products. Source: BioSpace You Might Also Like DURECT Stock Plunges as Pain Med Fails Phase III October 19, 2017 Tonix Pharma Prices Public Offering Of 1,800,000 Shares Of Common Stock March 29, 2017 Ag Biotech Company Announces $24MM C Round Financing July 9, 2017
